• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Netherlands - No evidence of adverse pregnancy outcome among women with Q-fever antibodies during early pregnancy.

Gert van der Hoek

In Memoriam - Editor, Senior Moderator
2011-02-11

Antibodies against Coxiella burnetii and pregnancy outcome during the 2007-2008 Q fever outbreaks in the Netherlands

Q fever has become a major public health problem in the Netherlands. Infection with Coxiella burnetii (Q fever) during pregnancy has resulted in adverse pregnancy outcome in the majority of reported cases.

Therefore, we aimed to quantify this risk by examining the earliest periods corresponding to the epidemic in the Netherlands.

Methods: Serum samples that had been collected from the area of highest incidence by an existing national prenatal screening programme and data from the Netherlands Perinatal Registry (PRN) on diagnosis and outcome were used. We performed indirect immunofluorescence assay to detect the presence of IgM and IgG antibodies against C.

burnetii in the samples. The serological results were analyzed to determine statistical association with recorded pregnancy outcome.

Results: Evaluation of serological results for 1174 women in the PRN indicated that the presence of IgM and IgG antibodies against phase II of C.

burnetii was not significantly associated with preterm delivery, low birth weight, or several other outcome measures.

Conclusion: The present population-based study showed no evidence of adverse pregnancy outcome among women who had antibodies to C. burnetii during early pregnancy.

Author: Wim van der HoekJamie C.E. MeekelenkampAlexander C.A.P. LeendersNancy WijersDaan W. NotermansChantal W.P.M. Hukkelhoven

Credits/Source: BMC Infectious Diseases 2011, 11:44


7thspace.com
 
Back
Top